Concepedia

Jessica E. Sutherland

JE

Statistics

Publications

19

Citations

1.3K

H-Index

14

Active since

1946

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

New York University

Toronto Metropolitan University

IQVIA (United Kingdom)

University of Wisconsin–Madison

Jessica E. Sutherland is an author at Alnylam Pharmaceuticals (United States) specializing in rna interference, pharmacology, and pharmacy.

Publications per year

1946–2022

19

Publications

19

Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial

Kevin Fitzgerald, Maria Frank-Kamenetsky, Svetlana Shulga‐Morskaya et al. · The Lancet · 2013 · 574 citations

Life Sciences, Biochemistry, Pharmacology +16

Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates

Kirk Brown, Jayaprakash K. Nair, Maja M. Janas et al. · Nature Biotechnology · 2022 · 245 citations

Pharmacy, Molecular Biology, Pharmacology +16

Safety evaluation of 2′-deoxy-2′-fluoro nucleotides in GalNAc-siRNA conjugates

Maja M. Janas, Ivan Zlatev, Ju Liu et al. · Nucleic Acids Research · 2019 · 77 citations · Full text

Pharmacy, Molecular Biology, Pharmacology +16

The Role of Oxidative Stress in Nickel and Chromate Genotoxicity

Max Costa, Konstantin Salnikow, Jessica E. Sutherland et al. · 2002 · 51 citations

Pharmacy, Biochemistry, Toxicology +14

Rats Retain Chromium in Tissues Following Chronic Ingestion of Drinking Water Containing Hexavalent Chromium

Jessica E. Sutherland, Anatoly Zhitkovich, Tomasz Kluz et al. · Biological Trace Element Research · 2000 · 47 citations

Veterinary Medicine, Biochemistry, Toxicology +9

1–5 of 19